MIM Software
2024
Why
Enhanced advanced imaging software capabilities in radiation oncology, molecular imaging, and theranostics.
GE HealthCare
Acquisitions
4
Major Deals Covered
This page covers 4 major deals from 2004 to 2024, each with its price where disclosed and the reason behind it.
| Company | Year | Price | Purpose |
|---|---|---|---|
| 2004 | Undisclosed | — | |
| 2023 | Undisclosed | — | |
| 2024 | Undisclosed | — | |
| 2017 | Undisclosed | — |
2024
Enhanced advanced imaging software capabilities in radiation oncology, molecular imaging, and theranostics.
2023
Brought cutting-edge AI guidance technology to ultrasound, enabling non-experts to capture diagnostic-quality cardiac images.
2017
Strengthened bioprocess purification technologies for biopharmaceutical manufacturing.
2004
Transformed GE Healthcare into a leader in pharmaceutical diagnostics, contrast agents, and molecular imaging.
Focusing on organic R&D innovation in AI-powered medical imaging, expanding digital health platforms like Edison, scaling pharmaceutical diagnostics, and pursuing targeted acquisitions such as Caption Health and MIM Software.
GE HealthCare operates a high-margin recurring revenue model combining capital equipment sales of advanced medical imaging systems (MRI, CT, PET/CT, Ultrasound) with long-term service agreements, software upgrade subscriptions, AI clinical applications, and consumable pharmaceutical diagnostics (contrast agents and radiotracers).
undefined pursues a disciplined, strategic M&A approach focused on acquiring proprietary technologies, expanding customer distribution reach, and unlocking operational cost synergies rather than pursuing unselective scale.
Transformative transactions in undefined's history include pivotal mergers and acquisitions that secured key regional footprints, consolidated core market share, and brought proprietary software intellectual property in-house.
undefined deploys dedicated integration teams to harmonize core software stacks, align regulatory compliance systems, and unite company cultures while preserving entrepreneurial agility.
Yes, undefined periodically evaluates its corporate portfolio, strategically divesting non-core or non-strategic assets to redeploy capital into high-margin core operational divisions.
Compare corporate acquisition records, deal values, and strategic targets
Explore GE HealthCare
Core profile pages, founders and related research hubs for this company.